Literature DB >> 28450949

Genetic variation in the 3'-untranslated region of PAK1 influences schizophrenia susceptibility.

Juan Jiang1, Jianxiong Long1, Weijun Ling1, Guifeng Huang1, Li Su1.   

Abstract

The present study aimed to investigate the association of two polymorphisms (rs2844337 and rs11237200) in the P21 protein (cell division control protein 42/Rac)-activated kinase 1 gene with susceptibility to schizophrenia (SCZ) in Chinese Zhuang and Chinese Han populations. A total of 700 patients with SCZ and 700 healthy controls were recruited. Rs2844337 and rs11237200 polymorphisms were genotyped using Sequenom technology. A total of 591 patients completed the Positive and Negative Syndrome Scale (PANSS) assessment. Data were statistically analyzed using PLINK version 1.07 and SPSS version 17.0. In the Chinese Han population, the genotypic (P=0.038) and allelic (P=0.033) frequencies of the 3'-untranslated region (UTR) genetic variation of rs2844337 in patients were significantly decreased compared to that in controls; these frequencies were significantly associated with SCZ susceptibility in the additive model (Padj=0.032) and in the recessive model (Padj=0.031). Moreover, the TG haplotype constructed by rs2844337 and rs11237200 polymorphisms remained significantly associated with SCZ risk following adjustment for gender and age and applying a Bonferroni correction in the Chinese Han population (Padj=0.003, PBC=0.009). The adjacent 5'-UTR genetic variation of rs11237200 was significantly associated with the total score (Padj=0.006), positive scale score (Padj=0.014) and general psychopathology scale scores (Padj=0.009) in the recessive model of the Chinese Han population. However, these polymorphisms were not significantly associated with SCZ susceptibility or the PANSS scores in the Chinese Zhuang population. In conclusion, variations in the PAK1 gene influenced the susceptibility and severity of the clinical symptoms of SCZ in the Chinese Han population investigated in the present study.

Entities:  

Keywords:  P21 protein-activated kinase 1 gene; clinical symptom; polymorphism; schizophrenia; susceptibility

Year:  2017        PMID: 28450949      PMCID: PMC5403403          DOI: 10.3892/etm.2017.4039

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  47 in total

1.  Identification of loci associated with schizophrenia by genome-wide association and follow-up.

Authors:  Michael C O'Donovan; Nicholas Craddock; Nadine Norton; Hywel Williams; Timothy Peirce; Valentina Moskvina; Ivan Nikolov; Marian Hamshere; Liam Carroll; Lyudmila Georgieva; Sarah Dwyer; Peter Holmans; Jonathan L Marchini; Chris C A Spencer; Bryan Howie; Hin-Tak Leung; Annette M Hartmann; Hans-Jürgen Möller; Derek W Morris; Yongyong Shi; GuoYin Feng; Per Hoffmann; Peter Propping; Catalina Vasilescu; Wolfgang Maier; Marcella Rietschel; Stanley Zammit; Johannes Schumacher; Emma M Quinn; Thomas G Schulze; Nigel M Williams; Ina Giegling; Nakao Iwata; Masashi Ikeda; Ariel Darvasi; Sagiv Shifman; Lin He; Jubao Duan; Alan R Sanders; Douglas F Levinson; Pablo V Gejman; Sven Cichon; Markus M Nöthen; Michael Gill; Aiden Corvin; Dan Rujescu; George Kirov; Michael J Owen; Nancy G Buccola; Bryan J Mowry; Robert Freedman; Farooq Amin; Donald W Black; Jeremy M Silverman; William F Byerley; C Robert Cloninger
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

2.  Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder.

Authors:  Glenn T Konopaske; Nicholas Lange; Joseph T Coyle; Francine M Benes
Journal:  JAMA Psychiatry       Date:  2014-12-01       Impact factor: 21.596

3.  MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant.

Authors:  Sandra Shi; Catherine Leites; Deli He; Daniel Schwartz; Winton Moy; Jianxin Shi; Jubao Duan
Journal:  J Biol Chem       Date:  2014-03-27       Impact factor: 5.157

4.  Influence of NRGN rs12807809 polymorphism on symptom severity in individuals with schizophrenia in the Han population but not the Zhuang population of south China.

Authors:  Li Su; Jianxiong Long; Runde Pan; Xinfeng Xie; Xixiang Mao; Yang Zhou; Qiang Chen; Bo Wei
Journal:  Acta Neuropsychiatr       Date:  2015-03-05       Impact factor: 3.403

5.  Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia.

Authors:  Dibyadeep Datta; Dominique Arion; John P Corradi; David A Lewis
Journal:  Biol Psychiatry       Date:  2015-04-11       Impact factor: 13.382

6.  Lipoprotein lipase gene polymorphism at the PvuII locus and serum lipid levels in Guangxi Hei Yi Zhuang and Han populations.

Authors:  Ruixing Yin; Yong Wang; Guangqin Chen; Weixiong Lin; Dezhai Yang; Shangling Pan
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

Review 7.  Diagnosis and classification of schizophrenia.

Authors:  N C Andreasen; W T Carpenter
Journal:  Schizophr Bull       Date:  1993       Impact factor: 9.306

8.  PPARα-L162V polymorphism is not associated with schizophrenia risk in a Croatian population.

Authors:  S Nadalin; J Giacometti; A Buretić-Tomljanović
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-07-12       Impact factor: 4.006

Review 9.  Schizophrenia.

Authors:  Kim T Mueser; Susan R McGurk
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

10.  Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding.

Authors:  Viviana Caputo; Lorenzo Sinibaldi; Alessia Fiorentino; Chiara Parisi; Caterina Catalanotto; Augusto Pasini; Carlo Cogoni; Antonio Pizzuti
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.